Skip to main content

Table 1 Demographics of populations

From: The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline

 

Safety Population (n = 646)

Efficacy Population (n = 592)

Age (yrs)

34.8 (6 to 83)

34.7 (6 to 83)

Gender

47% M: 53% F

46% M: 54% F

Race

91% Caucasian

91% Caucasian

BMI (kg/m2)

25.5 (0.6)

25.5 (0.6)

Height (cm)

164.2 (14.0)

164.3 (13.9)

Weight (kg)

70.2 (21.6)

70.1 (21.6)

Asthmatics (n)

551

505

FEV1 (L)

3.0 (0.9)

3.0 (0.9)

% Predicted FEV1

95.0 (14.5)

95.5 (14.7)

Non-asthmatics (n)

95

91

FEV1 (L)

3.2 (0.9)

3.2 (0.9)

% Predicted FEV1

94.6 (14.1)

95.2 (14.4)